Login
$CYAB
$0.13 -$0.00 (0.83%) Close

Consolidated Interim Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Assets
Current assets
Cash and cash equivalents
Restricted cash
Accounts receivable
Other current assets
Total current assets
Non-Current Assets
Operating right-of-use asset
Property and equipment, net
Other assets
Total non-current assets
Total Assets
Liabilities, Redeemable Convertible Preferred Shares and Capital Deficiency
Current liabilities
Trade accounts payable
Accrued expenses
Short term loans
Operating lease liability
Deferred revenues
Employees and related
Other current liabilities
Related Party
Total other current liabilities
Convertible notes
Liability with respect to warrants
Total current liabilities
Non-Current Liabilities
Operating lease liability
Long-term deferred revenues
Liability with respect to warrants
Total non-current liabilities
Total liabilities
Redeemable Convertible Preferred Shares:
Preferred shares, value
Capital Deficiency:
Class A common stock
Additional paid in capital
Accumulated deficit
Total capital deficiency
Total liabilities, redeemable convertible preferred shares and capital deficiency

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support